174 related articles for article (PubMed ID: 9744531)
1. The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism.
Cavin C; Holzhäuser D; Constable A; Huggett AC; Schilter B
Carcinogenesis; 1998 Aug; 19(8):1369-75. PubMed ID: 9744531
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of coffee diterpenes against aflatoxin B1-induced genotoxicity: mechanisms in rat and human cells.
Cavin C; Mace K; Offord EA; Schilter B
Food Chem Toxicol; 2001 Jun; 39(6):549-56. PubMed ID: 11346484
[TBL] [Abstract][Full Text] [Related]
3. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity.
Cavin C; Holzhaeuser D; Scharf G; Constable A; Huber WW; Schilter B
Food Chem Toxicol; 2002 Aug; 40(8):1155-63. PubMed ID: 12067578
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the chemoprotective enzymes glucuronosyl transferase and glutathione transferase in specific organs of the rat by the coffee components kahweol and cafestol.
Huber WW; Prustomersky S; Delbanco E; Uhl M; Scharf G; Turesky RJ; Thier R; Schulte-Hermann R
Arch Toxicol; 2002 May; 76(4):209-17. PubMed ID: 12029384
[TBL] [Abstract][Full Text] [Related]
5. The model Ah-receptor agonist beta-naphthoflavone inhibits aflatoxin B1-DNA binding in vivo in rainbow trout at dietary levels that do not induce CYP1A enzymes.
Takahashi N; Harttig U; Williams DE; Bailey GS
Carcinogenesis; 1996 Jan; 17(1):79-87. PubMed ID: 8565141
[TBL] [Abstract][Full Text] [Related]
6. Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepatic N-acetyltransferase and glutathione S-transferase activities.
Huber WW; Teitel CH; Coles BF; King RS; Wiese FW; Kaderlik KR; Casciano DA; Shaddock JG; Mulder GJ; Ilett KF; Kadlubar FF
Environ Mol Mutagen; 2004; 44(4):265-76. PubMed ID: 15468054
[TBL] [Abstract][Full Text] [Related]
7. Coffee and its chemopreventive components Kahweol and Cafestol increase the activity of O6-methylguanine-DNA methyltransferase in rat liver--comparison with phase II xenobiotic metabolism.
Huber WW; Scharf G; Nagel G; Prustomersky S; Schulte-Hermann R; Kaina B
Mutat Res; 2003 Jan; 522(1-2):57-68. PubMed ID: 12517412
[TBL] [Abstract][Full Text] [Related]
8. Placental glutathione S-transferase (GST-P) induction as a potential mechanism for the anti-carcinogenic effect of the coffee-specific components cafestol and kahweol.
Schilter B; Perrin I; Cavin C; Huggett AC
Carcinogenesis; 1996 Nov; 17(11):2377-84. PubMed ID: 8968051
[TBL] [Abstract][Full Text] [Related]
9. Coffee diterpenes prevent benzo[a]pyrene genotoxicity in rat and human culture systems.
Cavin C; Bezencon C; Guignard G; Schilter B
Biochem Biophys Res Commun; 2003 Jun; 306(2):488-95. PubMed ID: 12804590
[TBL] [Abstract][Full Text] [Related]
10. The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat.
Huber WW; Scharf G; Rossmanith W; Prustomersky S; Grasl-Kraupp B; Peter B; Turesky RJ; Schulte-Hermann R
Arch Toxicol; 2002 Jan; 75(11-12):685-94. PubMed ID: 11876501
[TBL] [Abstract][Full Text] [Related]
11. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
12. Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2).
Majer BJ; Hofer E; Cavin C; Lhoste E; Uhl M; Glatt HR; Meinl W; Knasmüller S
Food Chem Toxicol; 2005 Mar; 43(3):433-41. PubMed ID: 15680679
[TBL] [Abstract][Full Text] [Related]
13. Cafestol, the cholesterol-raising factor in boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase in rat hepatocytes.
Post SM; de Wit EC; Princen HM
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3064-70. PubMed ID: 9409294
[TBL] [Abstract][Full Text] [Related]
14. Induction of Nrf2-mediated cellular defenses and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liver.
Cavin C; Marin-Kuan M; Langouët S; Bezençon C; Guignard G; Verguet C; Piguet D; Holzhäuser D; Cornaz R; Schilter B
Food Chem Toxicol; 2008 Apr; 46(4):1239-48. PubMed ID: 17976884
[TBL] [Abstract][Full Text] [Related]
15. Heterologous expression of CYP2K1 and identification of the expressed protein (BV-CYP2K1) as lauric acid (omega-1)-hydroxylase and aflatoxin B1 exo-epoxidase.
Yang YH; Miranda CL; Henderson MC; Wang-Buhler JL; Buhler DR
Drug Metab Dispos; 2000 Nov; 28(11):1279-83. PubMed ID: 11038153
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of aflatoxin B1 by rabbit and rat nasal mucosa microsomes and purified cytochrome P450, including isoforms 2A10 and 2A11.
Putt DA; Ding X; Coon MJ; Hollenberg PF
Carcinogenesis; 1995 Jun; 16(6):1411-7. PubMed ID: 7788862
[TBL] [Abstract][Full Text] [Related]
17. 2-(Allylthio)pyrazine inhibition of aflatoxin B1-induced hepatocarcinogenesis in rats.
Ha TG; Jang JJ; Kim SG; Kim ND
Chem Biol Interact; 1999 Jul; 121(2):209-22. PubMed ID: 10418965
[TBL] [Abstract][Full Text] [Related]
18. Effect of diet on aflatoxin B1-DNA binding and aflatoxin B1-induced glutathione S-transferase placental form positive hepatic foci in the rat.
Kimura M; Lehmann K; Gopalan-Kriczky P; Lotlikar PD
Exp Mol Med; 2004 Aug; 36(4):351-7. PubMed ID: 15365254
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism.
Manson MM; Ball HW; Barrett MC; Clark HL; Judah DJ; Williamson G; Neal GE
Carcinogenesis; 1997 Sep; 18(9):1729-38. PubMed ID: 9328168
[TBL] [Abstract][Full Text] [Related]
20. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
